Three companies, including Hyundai Pharmaceuticals, were fined up to KRW 1.6 billion for accounting violations

Reporter Kim Jisun / approved : 2023-09-14 02:44:51
  • -
  • +
  • 인쇄
 

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] At the 16th meeting on the 13th, the Financial Services Commission decided to impose fines on three companies, including Hyundai Pharmaceutical, company officials and accounting firms, who prepared and disclosed financial statements in violation of accounting standards.

Hyundai Pharmaceutical, which has the largest fine, was fined 1.6578 billion won for writing in violation of accounting standards. On the same charges, two people, including the former CEO, were fined 331.4 million won, while the Korea Accounting Corporation, which neglected the audit process, was fined 60.9 million won.

The Financial Services Commission imposed a fine of 553.6 million won on DA Technology for the same charges. Three former CEOs were charged 165.9 million won and 82.5 million won for accounting firms.

Four people, including the former CEO of listed company Mediforum, were also fined 331.4 million won for preparing financial statements in violation of accounting standards.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Lotte Chilsung to Offer First-Ever Voluntary Retirement Program in 75 Years2025.11.07
Police Refer Former Doosan Bobcat Korea Executives to Prosecutors Over Bid-Rigging and Bribery Allegations2025.11.07
SK Group to Launch Early Year-End Executive Reshuffle; Major Layoffs Expected at SK Telecom2025.11.07
KT Accused of Concealing 2024 Malware Infection Affecting Subscriber Data; Government Probe Finds Security Failures Behind Micropayment Hacking2025.11.07
Korea’s National Pension Service Gains Strong Q3 Returns from U.S. Tech Stocks Amid Market Rally2025.11.07
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사